share_log

Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study

Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study

默沙東結束了Keytruda高風險黑色素瘤研究的聯合配方組
WSJ ·  05/13 07:45

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論